Fractal organization of the human T cell repertoire in health and after stem cell transplantation

Biol Blood Marrow Transplant. 2013 Mar;19(3):366-77. doi: 10.1016/j.bbmt.2012.12.004. Epub 2013 Jan 11.

Abstract

T cell repertoire diversity is generated in part by recombination of variable (V), diversity (D), and joining (J) segments in the T cell receptor β (TCR) locus. T cell clonal frequency distribution determined by high-throughput sequencing of TCR β in 10 stem cell transplantation (SCT) donors revealed a fractal, self-similar frequency distribution of unique TCR bearing clones with respect to V, D, and J segment usage in the T cell repertoire of these individuals. Further, ranking of T cell clones by frequency of gene segment usage in the observed sequences revealed an ordered distribution of dominant clones conforming to a power law, with a fractal dimension of 1.6 and 1.8 in TCR β DJ and VDJ containing clones in healthy stem cell donors. This self-similar distribution was perturbed in the recipients after SCT, with patients demonstrating a lower level of complexity in their TCR repertoire at day 100 followed by a modest improvement by 1 year post-SCT. A large shift was observed in the frequency distribution of the dominant T cell clones compared to the donor, with fewer than one third of the VDJ-containing clones shared in the top 4 ranks. In conclusion, the normal T cell repertoire is highly ordered with a TCR gene segment usage that results in a fractal self-similar motif of pattern repetition across levels of organization. Fractal analysis of high-throughput TCR β sequencing data provides a comprehensive measure of immune reconstitution after SCT.

Publication types

  • Clinical Trial, Phase II
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antilymphocyte Serum / pharmacology
  • Antilymphocyte Serum / therapeutic use
  • Clone Cells
  • Fractals
  • Hematologic Neoplasms / immunology
  • Hematologic Neoplasms / pathology
  • Hematologic Neoplasms / therapy
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Myeloablative Agonists / pharmacology
  • Myeloablative Agonists / therapeutic use
  • Receptors, Antigen, T-Cell, alpha-beta / chemistry
  • Receptors, Antigen, T-Cell, alpha-beta / genetics*
  • Receptors, Antigen, T-Cell, alpha-beta / immunology
  • Stem Cell Transplantation*
  • T-Lymphocytes / classification
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / pathology
  • Transplantation Chimera / immunology
  • Transplantation Conditioning*
  • Transplantation, Homologous

Substances

  • Antilymphocyte Serum
  • Myeloablative Agonists
  • Receptors, Antigen, T-Cell, alpha-beta